| Gene symbol | IL24 | Synonyms | C49A, FISP, IL10B, MDA7, MOB5, ST16 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q32.1 | dbXrefs | |
| Description | interleukin 24 | ||||
| GTO ID | GTC1229 |
| Trial ID | NCT00116363 |
| Disease | Metastatic Melanoma |
| Altered gene | MDA-7 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | INGN 241 |
| Phase | Phase2 |
| Recruitment status | Unknown |
| Title | Phase II Study Examining the Biological Efficacy of Intratumoral INGN 241 (Ad-mda7) Administration in Patients With In Transit Melanoma |
| Year | 2005 |
| Country | United States |
| Company sponsor | Introgen Therapeutics |
| Other ID(s) | INT 241-004|2003-0590, R43 CA 89778 |
| Vector information | |||||||||||||
|
|||||||||||||
| Cohort 1 | |||||||
|
|||||||